BR112013006515B1 - vacina de combinação, e, método para a fabricação de uma vacina de combinação - Google Patents
vacina de combinação, e, método para a fabricação de uma vacina de combinação Download PDFInfo
- Publication number
- BR112013006515B1 BR112013006515B1 BR112013006515A BR112013006515A BR112013006515B1 BR 112013006515 B1 BR112013006515 B1 BR 112013006515B1 BR 112013006515 A BR112013006515 A BR 112013006515A BR 112013006515 A BR112013006515 A BR 112013006515A BR 112013006515 B1 BR112013006515 B1 BR 112013006515B1
- Authority
- BR
- Brazil
- Prior art keywords
- combination vaccine
- making
- vaccines
- combination
- vaccine
- Prior art date
Links
Classifications
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K39/00—Medicinal preparations containing antigens or antibodies
- A61K39/12—Viral antigens
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K39/00—Medicinal preparations containing antigens or antibodies
- A61K39/12—Viral antigens
- A61K39/295—Polyvalent viral antigens; Mixtures of viral and bacterial antigens
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K39/00—Medicinal preparations containing antigens or antibodies
- A61K39/395—Antibodies; Immunoglobulins; Immune serum, e.g. antilymphocytic serum
- A61K39/40—Antibodies; Immunoglobulins; Immune serum, e.g. antilymphocytic serum bacterial
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K39/00—Medicinal preparations containing antigens or antibodies
- A61K39/395—Antibodies; Immunoglobulins; Immune serum, e.g. antilymphocytic serum
- A61K39/42—Antibodies; Immunoglobulins; Immune serum, e.g. antilymphocytic serum viral
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P31/00—Antiinfectives, i.e. antibiotics, antiseptics, chemotherapeutics
- A61P31/12—Antivirals
-
- C—CHEMISTRY; METALLURGY
- C07—ORGANIC CHEMISTRY
- C07K—PEPTIDES
- C07K14/00—Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof
- C07K14/005—Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof from viruses
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K39/00—Medicinal preparations containing antigens or antibodies
- A61K2039/51—Medicinal preparations containing antigens or antibodies comprising whole cells, viruses or DNA/RNA
- A61K2039/525—Virus
- A61K2039/5254—Virus avirulent or attenuated
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K39/00—Medicinal preparations containing antigens or antibodies
- A61K2039/55—Medicinal preparations containing antigens or antibodies characterised by the host/recipient, e.g. newborn with maternal antibodies
- A61K2039/552—Veterinary vaccine
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K39/00—Medicinal preparations containing antigens or antibodies
- A61K2039/70—Multivalent vaccine
-
- C—CHEMISTRY; METALLURGY
- C12—BIOCHEMISTRY; BEER; SPIRITS; WINE; VINEGAR; MICROBIOLOGY; ENZYMOLOGY; MUTATION OR GENETIC ENGINEERING
- C12N—MICROORGANISMS OR ENZYMES; COMPOSITIONS THEREOF; PROPAGATING, PRESERVING, OR MAINTAINING MICROORGANISMS; MUTATION OR GENETIC ENGINEERING; CULTURE MEDIA
- C12N2770/00—MICROORGANISMS OR ENZYMES; COMPOSITIONS THEREOF; PROPAGATING, PRESERVING, OR MAINTAINING MICROORGANISMS; MUTATION OR GENETIC ENGINEERING; CULTURE MEDIA ssRNA viruses positive-sense
- C12N2770/00011—Details
- C12N2770/24011—Flaviviridae
- C12N2770/24311—Pestivirus, e.g. bovine viral diarrhea virus
- C12N2770/24322—New viral proteins or individual genes, new structural or functional aspects of known viral proteins or genes
-
- C—CHEMISTRY; METALLURGY
- C12—BIOCHEMISTRY; BEER; SPIRITS; WINE; VINEGAR; MICROBIOLOGY; ENZYMOLOGY; MUTATION OR GENETIC ENGINEERING
- C12N—MICROORGANISMS OR ENZYMES; COMPOSITIONS THEREOF; PROPAGATING, PRESERVING, OR MAINTAINING MICROORGANISMS; MUTATION OR GENETIC ENGINEERING; CULTURE MEDIA
- C12N2770/00—MICROORGANISMS OR ENZYMES; COMPOSITIONS THEREOF; PROPAGATING, PRESERVING, OR MAINTAINING MICROORGANISMS; MUTATION OR GENETIC ENGINEERING; CULTURE MEDIA ssRNA viruses positive-sense
- C12N2770/00011—Details
- C12N2770/24011—Flaviviridae
- C12N2770/24311—Pestivirus, e.g. bovine viral diarrhea virus
- C12N2770/24334—Use of virus or viral component as vaccine, e.g. live-attenuated or inactivated virus, VLP, viral protein
-
- C—CHEMISTRY; METALLURGY
- C12—BIOCHEMISTRY; BEER; SPIRITS; WINE; VINEGAR; MICROBIOLOGY; ENZYMOLOGY; MUTATION OR GENETIC ENGINEERING
- C12N—MICROORGANISMS OR ENZYMES; COMPOSITIONS THEREOF; PROPAGATING, PRESERVING, OR MAINTAINING MICROORGANISMS; MUTATION OR GENETIC ENGINEERING; CULTURE MEDIA
- C12N2770/00—MICROORGANISMS OR ENZYMES; COMPOSITIONS THEREOF; PROPAGATING, PRESERVING, OR MAINTAINING MICROORGANISMS; MUTATION OR GENETIC ENGINEERING; CULTURE MEDIA ssRNA viruses positive-sense
- C12N2770/00011—Details
- C12N2770/24011—Flaviviridae
- C12N2770/24311—Pestivirus, e.g. bovine viral diarrhea virus
- C12N2770/24361—Methods of inactivation or attenuation
- C12N2770/24362—Methods of inactivation or attenuation by genetic engineering
Abstract
vacina de combinação, e, método para a fabricação de uma vacina de combinação. a presente invneção se refere ao vírus bvd e aos seus usos, às vacinas e vacinas de combinação que compreendem um tal vírus, seu uso como um medicamento, seu uso no tratamento da diarréia viral bovina e aos métodos para a preparação de tais vacinas.
Applications Claiming Priority (3)
Application Number | Priority Date | Filing Date | Title |
---|---|---|---|
US38501010P | 2010-09-21 | 2010-09-21 | |
EP10177931 | 2010-09-21 | ||
PCT/EP2011/066377 WO2012038454A1 (en) | 2010-09-21 | 2011-09-21 | Bvdv vaccine |
Publications (2)
Publication Number | Publication Date |
---|---|
BR112013006515A2 BR112013006515A2 (pt) | 2016-08-02 |
BR112013006515B1 true BR112013006515B1 (pt) | 2020-04-28 |
Family
ID=43110616
Family Applications (1)
Application Number | Title | Priority Date | Filing Date |
---|---|---|---|
BR112013006515A BR112013006515B1 (pt) | 2010-09-21 | 2011-09-21 | vacina de combinação, e, método para a fabricação de uma vacina de combinação |
Country Status (11)
Country | Link |
---|---|
US (1) | US9878030B2 (pt) |
EP (1) | EP2618841B1 (pt) |
CN (1) | CN103338785B (pt) |
AU (1) | AU2011306957C1 (pt) |
BR (1) | BR112013006515B1 (pt) |
CA (1) | CA2811243C (pt) |
ES (1) | ES2606605T3 (pt) |
MX (1) | MX347911B (pt) |
RU (1) | RU2578943C2 (pt) |
WO (1) | WO2012038454A1 (pt) |
ZA (1) | ZA201301950B (pt) |
Families Citing this family (7)
Publication number | Priority date | Publication date | Assignee | Title |
---|---|---|---|---|
CN103338785B (zh) | 2010-09-21 | 2015-01-14 | 英特维特国际股份有限公司 | Bvdv疫苗 |
WO2014043215A1 (en) | 2012-09-11 | 2014-03-20 | The Texas A&M University System | Bi-specifc diabodies for masking and targeting vaccines |
CN105949286A (zh) * | 2016-07-04 | 2016-09-21 | 中国兽医药品监察所 | 牛病毒性腹泻病毒i型e2蛋白的表达及应用 |
CN108456663B (zh) * | 2018-03-26 | 2021-09-21 | 中国农业科学院兰州兽医研究所 | 一种1型牛病毒性腹泻病毒样颗粒及其制备与应用 |
CN108614121B (zh) * | 2018-05-04 | 2020-11-20 | 山东师范大学 | 牛病毒性腹泻病毒e2蛋白抗原多表位融合肽及其制备与应用 |
CN111533813B (zh) * | 2020-07-09 | 2020-10-16 | 苏州世诺生物技术有限公司 | 牛病毒性腹泻病毒重组亚单位疫苗 |
CN113403256B (zh) * | 2021-06-16 | 2023-04-18 | 中国农业科学院特产研究所 | 一种稳定产生牛病毒性腹泻病毒抗原的细胞系及抗体胶体金检测试纸条的制备方法 |
Family Cites Families (12)
Publication number | Priority date | Publication date | Assignee | Title |
---|---|---|---|---|
US6001613A (en) | 1996-05-24 | 1999-12-14 | Board Of Regents Of University Of Nebraska | Plasmid bearing a cDNA copy of the genome of bovine viral diarrhea virus, chimeric derivatives thereof, and method of producing an infectious bovine viral diarrhea virus using said plasmid |
EP0965639A1 (en) | 1998-06-05 | 1999-12-22 | Boehringer Ingelheim Vetmedica Gmbh | Attenuated pestiviruses |
US6168942B1 (en) | 1998-11-10 | 2001-01-02 | Pfizer Inc. | Attenuated forms of bovine viral diarrhea virus |
EP1104676A1 (en) | 1999-11-30 | 2001-06-06 | Boehringer Ingelheim Vetmedica Gmbh | Safe attenuated bovine viral diarrhea viruses for use in pregnant cows |
CA2363493C (en) | 2000-11-22 | 2006-06-06 | Xuemei Cao | Attenuated forms of bovine viral diarrhea virus |
US6974575B2 (en) * | 2001-08-28 | 2005-12-13 | Pfizer Inc. | Generation of type I/type II hybrid form of bovine viral diarrhea virus for use as vaccine |
DE10143813A1 (de) | 2001-09-06 | 2003-04-10 | Boehringer Ingelheim Vetmed | Infektiöser Rindervirusdiarrhoe-Virusklon |
EP1727562B1 (en) * | 2004-03-17 | 2008-06-18 | Pharmacia & Upjohn Company LLC | Method of vaccination against testicular bvdv infection |
DE102004025452A1 (de) * | 2004-05-19 | 2006-01-19 | Boehringer Ingelheim Vetmedica Gmbh | Vakzine enthaltend BVDV |
UY29915A1 (es) | 2005-11-15 | 2007-06-29 | Boehringer Ingelheim Vetmed | Vacuna combinada que comprende un virus atenuado de la diarrea viral bovina |
RU2524426C2 (ru) * | 2008-12-03 | 2014-07-27 | Пфайзер Инк. | ВИРУС ДИАРЕИ КРУПНОГО РОГАТОГО СКОТА С МОДИФИЦИРОВАННЫМ БЕЛКОМ Erns |
CN103338785B (zh) | 2010-09-21 | 2015-01-14 | 英特维特国际股份有限公司 | Bvdv疫苗 |
-
2011
- 2011-09-21 CN CN201180055945.8A patent/CN103338785B/zh not_active Expired - Fee Related
- 2011-09-21 CA CA2811243A patent/CA2811243C/en not_active Expired - Fee Related
- 2011-09-21 AU AU2011306957A patent/AU2011306957C1/en not_active Ceased
- 2011-09-21 MX MX2013003245A patent/MX347911B/es active IP Right Grant
- 2011-09-21 BR BR112013006515A patent/BR112013006515B1/pt not_active IP Right Cessation
- 2011-09-21 RU RU2013118351/15A patent/RU2578943C2/ru active
- 2011-09-21 US US13/825,050 patent/US9878030B2/en active Active
- 2011-09-21 EP EP11760764.8A patent/EP2618841B1/en active Active
- 2011-09-21 ES ES11760764.8T patent/ES2606605T3/es active Active
- 2011-09-21 WO PCT/EP2011/066377 patent/WO2012038454A1/en active Application Filing
-
2013
- 2013-03-14 ZA ZA2013/01950A patent/ZA201301950B/en unknown
Also Published As
Publication number | Publication date |
---|---|
ZA201301950B (en) | 2014-03-26 |
ES2606605T3 (es) | 2017-03-24 |
BR112013006515A2 (pt) | 2016-08-02 |
US20130195892A1 (en) | 2013-08-01 |
EP2618841B1 (en) | 2016-10-19 |
CN103338785A (zh) | 2013-10-02 |
AU2011306957B2 (en) | 2014-07-24 |
CN103338785B (zh) | 2015-01-14 |
CA2811243C (en) | 2019-03-05 |
RU2578943C2 (ru) | 2016-03-27 |
EP2618841A1 (en) | 2013-07-31 |
WO2012038454A1 (en) | 2012-03-29 |
AU2011306957C1 (en) | 2014-08-28 |
AU2011306957A1 (en) | 2013-04-11 |
RU2013118351A (ru) | 2014-10-27 |
MX2013003245A (es) | 2013-05-22 |
MX347911B (es) | 2017-05-17 |
US9878030B2 (en) | 2018-01-30 |
CA2811243A1 (en) | 2012-03-29 |
Similar Documents
Publication | Publication Date | Title |
---|---|---|
BR112013006515B1 (pt) | vacina de combinação, e, método para a fabricação de uma vacina de combinação | |
BR112012020839A2 (pt) | vacinas para uso na profilaxe e tratamento de doença de vírus da influenza | |
BR112018000862A2 (pt) | composições de vacina | |
EP4233898A3 (en) | Influenza mrna vaccines | |
ECSP15019323A (es) | Derivados de 5-fluoro-n-(piridin-2-il)piridin-2-amina que contienen un grupo sulfoximina | |
BR112015014482A2 (pt) | vacinas para vírus influenza e seus usos | |
BR112018013168A2 (pt) | vírus mutantes, método de preparação e uso dos mesmos | |
CL2013002712A1 (es) | Composicion inmunogénica para modular sistema inmune que comprende agentes con patrones asociados a bacterias, virus, hongos y levaduras, protozoos, helmintos y/o priones; uso para tratar enfermedades autoinmunes o infecciosas. | |
ECSP12011834A (es) | Composición farmacéutica, forma de dosificación farmacéutica, procedimiento para su preparación, métodos para su tratamiento y sus usos. | |
BR112017001310A2 (pt) | coronavírus | |
BR112013011194A2 (pt) | partículas de glicoproteína semelhantes a vírus (vlps) da raiva. | |
PH12015502230B1 (en) | Novel viral replication inhibitors | |
PE20151588A1 (es) | Vacuna contra el virus del dengue | |
BR112015025748A2 (pt) | construção de dna para imunomodulação, composição farmacêutica, vacina, e uso de uma construção de dna | |
MX2015007753A (es) | Composicion de vacunas para sujetos intactos. | |
BR112012030659A2 (pt) | parvovírus vivo atenuado, vacina, e, métodos para a fabricação de uma vacina, e para a preparação de um parvovírus mutante. | |
BR112017003462A2 (pt) | coronavírus bovino atenuado, vacina, e, método de vacinação de um bovino. | |
NZ715459A (en) | A hyperbarically-inactivated microorganism, immunogenic compositions comprising same and methods for producing same | |
CL2014003113A1 (es) | Composición que comprende bacterias inactivadas de alliivibrio wodanis; método de producción; uso para fabricar medicamento para tratar y/o prevenir wodanosis; y vacuna para peces. | |
CR20140189S (es) | Vacunas y metodos para crear una vacuna para inducir la inmunidad a todos los serotipos del virus del dengue | |
CL2016000787A1 (es) | Composición farmacéutica en forma de comprimido que comprende atazanavir y cobicistat; procedimiento de preparación; y uso de la composición para preparar un medicamento útil para tratar la infección por el virus de inmunodeficiencia humana (vih). | |
BR112014027885A2 (pt) | produção de ingredientes farmacêuticos ativos estéreis | |
AR082577A1 (es) | Vacunas de virus varicela zoster inactivado, metodos de produccion y uso de las mismas | |
BR112016030728A2 (pt) | método para tratar ou prevenir uma inflamação induzida por bactérias em um indivíduo, composição imunogênica, composição farmacêutica, uso da composição imunogênica, método para produzir uma composição imunogênica, e, método para tratar ou prevenir uma doença | |
AR091240A1 (es) | Vacuna de virus de schmallenberg (sbv), metodos de produccion y sus usos |
Legal Events
Date | Code | Title | Description |
---|---|---|---|
B07D | Technical examination (opinion) related to article 229 of industrial property law [chapter 7.4 patent gazette] | ||
B06F | Objections, documents and/or translations needed after an examination request according [chapter 6.6 patent gazette] | ||
B07G | Grant request does not fulfill article 229-c lpi (prior consent of anvisa) [chapter 7.7 patent gazette] |
Free format text: NOTIFICACAO DE DEVOLUCAO DO PEDIDO POR NAO SE ENQUADRAR NO ART. 229-C DA LPI. |
|
B06U | Preliminary requirement: requests with searches performed by other patent offices: procedure suspended [chapter 6.21 patent gazette] | ||
B09A | Decision: intention to grant [chapter 9.1 patent gazette] | ||
B16A | Patent or certificate of addition of invention granted [chapter 16.1 patent gazette] |
Free format text: PRAZO DE VALIDADE: 20 (VINTE) ANOS CONTADOS A PARTIR DE 21/09/2011, OBSERVADAS AS CONDICOES LEGAIS. |
|
B21F | Lapse acc. art. 78, item iv - on non-payment of the annual fees in time |
Free format text: REFERENTE A 11A ANUIDADE. |
|
B24J | Lapse because of non-payment of annual fees (definitively: art 78 iv lpi, resolution 113/2013 art. 12) |
Free format text: EM VIRTUDE DA EXTINCAO PUBLICADA NA RPI 2688 DE 12-07-2022 E CONSIDERANDO AUSENCIA DE MANIFESTACAO DENTRO DOS PRAZOS LEGAIS, INFORMO QUE CABE SER MANTIDA A EXTINCAO DA PATENTE E SEUS CERTIFICADOS, CONFORME O DISPOSTO NO ARTIGO 12, DA RESOLUCAO 113/2013. |